Article Versions Notes

de Glas NA, Bastiaannet E, van den Bos F, Mooijaart SP, van der Veldt AAM, Suijkerbuijk KPM, Aarts MJB, van den Berkmortel FWPJ, Blank CU, Boers-Sonderen MJ, et al. Toxicity, Response and Survival in Older Patients with Metastatic Melanoma Treated with Checkpoint Inhibitors. Cancers. 2021; 13(11):2826. https://doi.org/10.3390/cancers13112826

de Glas, Nienke A., Esther Bastiaannet, Frederiek van den Bos, Simon P. Mooijaart, Astrid A. M. van der Veldt, Karlijn P. M. Suijkerbuijk, Maureen J. B. Aarts, Franchette W. P. J. van den Berkmortel, Christian U. Blank, Marye J. Boers-Sonderen, and et al. 2021. "Toxicity, Response and Survival in Older Patients with Metastatic Melanoma Treated with Checkpoint Inhibitors" Cancers 13, no. 11: 2826. https://doi.org/10.3390/cancers13112826

de Glas, N. A., Bastiaannet, E., van den Bos, F., Mooijaart, S. P., van der Veldt, A. A. M., Suijkerbuijk, K. P. M., Aarts, M. J. B., van den Berkmortel, F. W. P. J., Blank, C. U., Boers-Sonderen, M. J., van den Eertwegh, A. J. M., de Groot, J.-W. B., Haanen, J. B. A. G., Hospers, G. A. P., Jalving, H., Piersma, D., van Rijn, R. S., ten Tije, A. J., Vreugdenhil, G., ... Kapiteijn, E. W. (2021). Toxicity, Response and Survival in Older Patients with Metastatic Melanoma Treated with Checkpoint Inhibitors. Cancers, 13(11), 2826. https://doi.org/10.3390/cancers13112826